|Articles|December 12, 2019
Almac Group and Exostar Collaborate
Advertisement
Almac Clinical Technologies, a member of the Almac Group, has announced the launch of an integration between its Interactive Response Technology platform-IXRS 3, and Exostar’s Identity and Access Management Platform.
To learn more about the collaboration, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
2
Utilizing Tech Tools to Accelerate Drug Development
3
Inside the Recruitment Bottlenecks Driving Trial Delays
4
ACT Brief: Tech-Driven Data Strategies and Long-Term Vaccine Success
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
